Short- and potential long-term adverse health outcomes of COVID-19: a rapid review

References

• World Health Organization. Coronavirus disease (COVID-2019) situation report - 163 2020 [updated July 28; cited 2020 Jul 29]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
   Google Scholar
• World Health Organization. Coronavirus worldwide graphs - recovered and discharged 2020 [updated July 28; cited 2020 Jul 29]. Available from: https://www.worldometers.info/coronavirus/worldwide-graphs/#recovered.
   Google Scholar
• National Heart Lung and Blood Institute. Looking forward: understanding the long-term effects of COVID-19 2020 [updated Jun 3; cited 2020 Jul 13]. Available from: https://www.nhlbi.nih.gov/news/2020/looking-forward-understanding-long-term-effects-covid-19.
   Google Scholar
• Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423.
   PubMed Web of Science ®Google Scholar
• Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215:108427.
   PubMed Web of Science ®Google Scholar
• Shah S, Danda D, Kavadichanda C, et al. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. 2020;40(10):1539–1554.
   PubMed Web of Science ®Google Scholar
• Fujinami RS, von Herrath MG, Christen U, et al. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19(1):80–94.
   PubMed Web of Science ®Google Scholar
• Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22.
   PubMed Web of Science ®Google Scholar
• Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16(8):413–414.
   PubMed Web of Science ®Google Scholar
• Ehrenfeld M, Tincani A, Andreoli L, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597.
   PubMed Web of Science ®Google Scholar
• Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–1424.
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147.
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847.
   PubMed Web of Science ®Google Scholar
• van Dam LF, Kroft LJM, van der Wal LI, et al. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: a different phenotype of thrombotic disease? Thromb Res. 2020;193:86–89.
   PubMed Web of Science ®Google Scholar
• White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123:S11–S17.
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436.
   PubMed Web of Science ®Google Scholar
• Hays P. Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? Future Oncol. 2020;16(20):1463–1474.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052–2059.
   PubMed Web of Science ®Google Scholar
• Wang Y, Dong C, Hu Y, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;296(2):E55–e64.
   PubMed Web of Science ®Google Scholar
• British Thoracic Society. BTS guidance on respiratory follow up of patients with radiologically confirmed COVID-19 pneumonia 2020 [updated 11 May 2020; cited 2020 Sep 29]. Available from: https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/resp-follow-up-guidance-post-covid-pneumonia/.
   Google Scholar
• Carfì A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605.
   PubMed Web of Science ®Google Scholar
• Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217.
   PubMed Web of Science ®Google Scholar
• Das KM, Lee EY, Singh R, et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging. 2017;27(3):342–349.
   PubMedGoogle Scholar
• Zhang P, Li J, Liu H, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8(1):8.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810.
   PubMed Web of Science ®Google Scholar
• Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352–2371.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhang W, Pan F, et al. The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res. 2020;21(1):125.
   PubMed Web of Science ®Google Scholar
• Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. Br Med J. 2020;368:m606.
   PubMed Web of Science ®Google Scholar
• Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313(3):264–274.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhou L, Sun X, et al. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. 2017;7(1):9110.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu H, Yang X, et al. Cardiac complications associated with the influenza viruses a subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care. Braz J Infect Dis. 2017;21(1):12–18.
   PubMed Web of Science ®Google Scholar
• Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667–678.
   PubMed Web of Science ®Google Scholar
• Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: a comprehensive review. World J Gastroenterol. 2020;26(19):2323–2332.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhao N, Shu Y, et al. Effect of gastrointestinal symptoms in patients with COVID-19. Gastroenterology. 2020;158(8):2294–2297.
   PubMed Web of Science ®Google Scholar
• Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833.e3.
   PubMed Web of Science ®Google Scholar
• Kukla M, Skonieczna-Żydecka K, Kotfis K, et al. COVID-19, MERS and SARS with concomitant liver injury-systematic review of the existing literature. J Clin Med. 2020;9(5):1420.
   PubMed Web of Science ®Google Scholar
• Chau T-N, Lee K-C, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302–310.
   PubMed Web of Science ®Google Scholar
• Alsaad KO, Hajeer AH, Al Balwi M, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology. 2018;72(3):516–524.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Garcia-Tsao G, Biggins SW, et al. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut. 2020 [29 Sep]. DOI:10.1136/gutjnl-2020-322118.
   Web of Science ®Google Scholar
• Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218.
   PubMed Web of Science ®Google Scholar
• Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;8(7):738–742.
   PubMed Web of Science ®Google Scholar
• University of Giessen. Renal outcome in patients with COVID-19. 2020;Trial ID: NCT04353583.
   Google Scholar
• Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389–397.
   PubMed Web of Science ®Google Scholar
• Parr SK, Matheny ME, Abdel-Kader K, et al. Acute kidney injury is a risk factor for subsequent proteinuria. Kidney Int. 2018;93(2):460–469.
   PubMed Web of Science ®Google Scholar
• Paderno A, Schreiber A, Grammatica A, et al. Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol. 2020;10(8):955–962.
   PubMed Web of Science ®Google Scholar
• Tong JY, Wong A, Zhu D, et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163(1):3–11.
   PubMed Web of Science ®Google Scholar
• Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA. 2020;323(24):2512–2514.
   PubMed Web of Science ®Google Scholar
• Zayet S, Klopfenstein T, Kovacs R, et al. Acute cerebral stroke with multiple infarctions and COVID-19, France, 2020. Emerg Infect Dis. 2020;26(9):2258–2260.
   PubMed Web of Science ®Google Scholar
• Zhao H, Shen D, Zhou H, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383–384.
   PubMed Web of Science ®Google Scholar
• Dixon L, Varley J, Gontsarova A, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e789.
   PubMed Web of Science ®Google Scholar
• Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020 [29 Sep]. DOI:10.1016/s2215-0366(20)30287-x.
   Web of Science ®Google Scholar
• Gabriel T, Galán JM. Stroke as a complication and prognostic factor of COVID-19 [Ictus como complicación y como factor pronóstico de COVID-19]. Neurología (English Edition). 2020;35(5):318–322.
   PubMed Web of Science ®Google Scholar
• Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke. 2020;15(4):385–389.
   PubMed Web of Science ®Google Scholar
• Chen Q, Cao C, Gong L, et al. Health related quality of life in stroke patients and risk factors associated with patients for return to work. Medicine (Baltimore). 2019;98(16):e15130.
   PubMed Web of Science ®Google Scholar
• Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212–e213.
   PubMed Web of Science ®Google Scholar
• Novak N, Peng W, Naegeli MC, et al. SARS-CoV-2, COVID-19, skin and immunology – what do we know so far? Allergy. 2020 [9 Sep]. DOI:10.1111/all.14498.
   Web of Science ®Google Scholar
• Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–77.
   PubMed Web of Science ®Google Scholar
• Sinadinos A, Shelswell J. Oral ulceration and blistering in patients with COVID-19. Evid Based Dent. 2020;21(2):49–49.
   PubMedGoogle Scholar
• Tammaro A, Adebanjo GAR, Parisella FR, et al. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020;34(7):e306–e307.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19–associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280–285.
   PubMed Web of Science ®Google Scholar
• Rahimi H, Tehranchinia Z. A comprehensive review of cutaneous manifestations associated with COVID-19. Biomed Res Int. 2020 [9 Sep]: 1236520. DOI:10.1155/2020/1236520.
   PubMed Web of Science ®Google Scholar
• Lu S, Lin J, Zhang Z, et al. Alert for non-respiratory symptoms of Coronavirus disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. 2020 [9 Sep]. DOI:10.1002/jmv.25776.
   Web of Science ®Google Scholar
• Holmes EA, O'Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547–560.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
   PubMed Web of Science ®Google Scholar
• Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–627.
   PubMed Web of Science ®Google Scholar
• Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–1367.
   PubMed Web of Science ®Google Scholar
• Mak IWC, Chu CM, Pan PC, et al. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31(4):318–326.
   PubMed Web of Science ®Google Scholar
• Lam MH, Wing YK, Yu MW, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142–2147.
   PubMedGoogle Scholar
• Park HY, Park WB, Lee SH, et al. Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea. BMC Public Health. 2020;20(1):605.
   PubMed Web of Science ®Google Scholar
• Wong SF, Chow KM, de Swiet M. Severe acute respiratory syndrome and pregnancy. BJOG. 2003;110(7):641–642.
   PubMed Web of Science ®Google Scholar
• Alserehi H, Wali G, Alshukairi A, et al. Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016;16:105.
   PubMed Web of Science ®Google Scholar
• Shek CC, Ng PC, Fung GP, et al. Infants born to mothers with severe acute respiratory syndrome. Pediatrics. 2003;112(4):e254.
   PubMed Web of Science ®Google Scholar
• Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. Br Med J. 2020;369:m2107.
   PubMed Web of Science ®Google Scholar
• Bauman MD, Van de Water J. Translational opportunities in the prenatal immune environment: promises and limitations of the maternal immune activation model. Neurobiol Dis. 2020;141:104864.
   PubMed Web of Science ®Google Scholar
• Tansey CM, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167(12):1312–1320.
   PubMedGoogle Scholar
• Hill AD, Fowler RA, Burns KE, et al. Long-term outcomes and health care utilization after prolonged mechanical ventilation. Ann Am Thorac Soc. 2017;14(3):355–362.
   PubMed Web of Science ®Google Scholar